According to Kalorama Information, the U.S. IVD market reached $53 billion in 2022, or approximately 40% to 45% of the global market. Projected growth is 2.4% annually on average through 2027.

Bio-economy is a new economic form based on the development progress and popular application of life science and biotechnology, and is an important part of the national economy.

Supplies of laboratory reagents, testing components and transport media are expected to normalize in the first half of 2023, ending shortages that date back to early in the pandemic, according to the Food and Drug Administration.

BostonGene said on Wednesday that it is collaborating with the Little Warrior Foundation to develop liquid biopsy assays for the detection of sarcoma-related molecular alterations and gene fusions.

Which segmentations will have a broader development prospect in the Chinese IVD field?

Roche said Wednesday that it has entered a collaboration with drug maker Eli Lilly to support development of Roche's Elecsys Amyloid Plasma Panel (EAPP), a blood test for aiding earlier diagnosis of Alzheimer's disease.

Genomadix announced on Wednesday that the US Food and Drug Administration has granted 510(k) clearance to its automated sample-to-result Genomadix Cube PCR system and CYP2C19 test.

On March 21, according to the Qichacha data, the major shareholders of Shenzhen Thistory Bio-Medical Company have been changed from Shenzhen Thistory Bio-medical Management and Consulting Enterprise to Zybio Inc.

Researchers in Spain have evaluated a minimally invasive test based on dried blood spot samples for hepatitis C RNA detection and genotyping.

Point-of-care diagnostics firm LumiraDx on Tuesday reported a 65 percent decrease in its fourth quarter revenues.

In March 2023, Cygnus received another round of Series C+ financing of hundreds of millions of RMB, led by Source Capital, and followed by Jianxin Equity, Yizhuang State Investment, Fangzhenghesheng, and Hetang Venture Capital.

DiaSorin said late Friday that it has nabbed US Food and Drug Administration 510(k) clearance for a molecular assay that differentiates between infections with the SARS-CoV-2 and influenza A and B viruses.

Cue Health announced on Monday that it has received Emergency Use Authorization from the US Food and Drug Administration for its molecular monkeypox test.

On March 18th, at the 8th E-Trade Bioindustry Conference of 2023EBC, MGI Tech held the "DNBSEQ-G99 Signing Ceremony" and reached cooperation with 6 enterprise partners to develop G99-based application expansion.

Digital health company Biostarks has announced new at-home longevity test kits that leverage the firm’s mass-spectrometry platform.

Enzo Biochem said after the close of markets on Thursday that it has entered an agreement to sell the assets of its clinical laboratory division to Laboratory Corporation of America.

The February operating data of the three major airlines, China Eastern Airlines (MU), China Southern Airlines (CZ) & Air China (CA) were released.

Werfen announced that it has successfully completed the acquisition of Immucor, Inc., after obtaining all necessary regulatory and antitrust approvals.

Liquid handling instrumentation firm Integra Biosciences said that it has acquired Miroculus, a sample prep automation company that has been developing microfluidics-based platforms for next-generation sequencing.

Becton Dickinson announced that it received 510(k) clearance from the US Food and Drug Administration for a high-throughput assay to detect vaginitis.